← Back to patent-cliff list
SS-001(Suzhou Pairui Biotech)
Tier C — Watch / tradeSS-001(Suzhou Pairui Biotech)
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：手-足综合征, 手部皮肤病, 足部皮肤病
Regional status
US
-
EU
-
China
Phase II
2025-10-31
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of SS-001(Suzhou Pairui Biotech)?
Approved indications include: 手-足综合征, 手部皮肤病, 足部皮肤病.
When does the SS-001(Suzhou Pairui Biotech) patent expire?
No public expiry year is available for SS-001(Suzhou Pairui Biotech) yet; this page updates once verified.
How do I get a quote for SS-001(Suzhou Pairui Biotech) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-30